Binding domain-driven intracellular trafficking of sterols for synthesis of steroid hormones, bile acids and oxysterols

Traffic

Volumn 15, Issue 9, 2014, Pages 895-914

  Midzak, Andrew ^a   Papadopoulos, Vassilios ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cholesterol; Mitochondria; Protein motifs; Steroidogenesis; Steroids; Sterol trafficking

Indexed keywords

BILE ACID; GLYCOPROTEIN; NIEMANN PICK TYPE C PROTEIN; OXYSTEROL; PROTEIN STARD3; PROTEIN STARD4; PROTEIN STARD5; PROTEIN STARD6; STEROID HORMONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROL; UNCLASSIFIED DRUG; CARRIER PROTEIN; CHOLESTEROL; SEX HORMONE;

BILE ACID SYNTHESIS; BINDING AFFINITY; CELL MIGRATION; CHOLESTEROL METABOLISM; HOMEOSTASIS; HORMONE SYNTHESIS; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; STEROIDOGENESIS; ANIMAL; HUMAN; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CHOLESTEROL; GONADAL STEROID HORMONES; HOMEOSTASIS; HUMANS; LIPID METABOLISM; PROTEIN STRUCTURE, TERTIARY; STEROLS;

EID: 84906320367     PISSN: 13989219     EISSN: 16000854     Source Type: Journal    
DOI: 10.1111/tra.12177     Document Type: Review

References (193)

1. Miller WL, Bose HS. Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res 2011;52:2111-2135.
2. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev 2004;25:947-970.
3. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011;32:81-151.
4. Hoffmann AF, Hagey LR, Krasowski MD. Bile salts of vertebrates: structural variation and possible evolutionary significance. J Lipid Res 2010;51:226-246.
5. Brown MR, Sieglaff DH, Rees HH. Gonadal ecdysteroidogenesis in Arthropoda: occurrence and regulation. Annu Rev Entomol 2009;54:105-125.
6. Chambon P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 2005;19:1418-1428.
7. Evans RM. The nuclear receptor superfamily: a Rosetta stone for physiology. Mol Endocrinol 2005;19:1429-1438.
8. Miller WL. A brief history of adrenal research. Steroidogenesis - the soul of the adrenal. Mol Cell Endocrinol 2013;371:5-14.
9. Gonzalez FJ. The molecular biology of cytochrome P450s. Pharmacol Rev 1988;40:243-288.
10. Miller WL. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 2005;146:2544-2550.
11. Agarwal AK, Auchus RJ. Cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005;146:2531-2538.
12. Thomas JL, Duax WL, Addlagatta A, Brandt S, Fuller RR, Norris W. Structure/function relationships responsible for coenzyme specificity and the isomerase activity of human type 1 β-hydroxysteroid dehydrogenase/isomerase. J Biol Chem 2003;278:35483-35490.
13. Lathe R, Kotelevsky Y. Steroid signaling: ligand-binding promiscuity, molecular symmetry, and the need for gating. Steroids 2014;82C:14-22.
14. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 2006;138:749-756.
15. Shikita M, Hall PF. Cytochrome P-450 from bovine adrenocortical mitochondria: an enzyme for the side chain cleavage of cholesterol. I. Purification and properties. J Biol Chem 1973;248:5598-5604.
16. Norlin M, Wikvall K. Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med 2007;7:199-218.
17. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, Ohnishi T, Ichikawa Y, Nakaok K, Imura H, Ulick S, Shizuta Y. Role of steroid 11β-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 1992;89:1458-1462.
18. Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, Kato S. 25-Hydroxyvitamin D3 1a-hydroxylase and vitamin D synthesis. Science 1997;277:1827-1830.
19. Pikuleva IA, Waterman MR. Cytochromes p450: roles in diseases. J Biol Chem 2013;288:17091-17098.
20. Markov GV, Tavares R, Dauphin-Villemant C, Demeneix BA, Baker ME, Laudet V. Independent elaboration of steroid hormone signaling pathways in metazoans. Proc Natl Acad Sci U S A 2009;106:11913-11918.
21. Fan J, Papadopoulos V. Evolutionary origin of the mitochondrial cholesterol transport machinery reveals a universal mechanism of steroid hormone biosynthesis in animals. PLoS One 2013;8:e76701.
22. Burstein S, Gut M. Intermediates in the conversion of cholesterol to pregnenolone: kinetics and mechanism. Steroids 1976;28:115-131.
23. Mast N, Annalora AJ, Lodowski DT, Palczewski K, Stout CD, Pikuleva IA. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J Biol Chem 2011;286:5607-5613.
24. Strushkevich N, MacKenzie F, Cherkesova T, Grabovec I, Usanov S, Park HW. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc Natl Acad Sci U S A 2011;108:10139-10143.
25. Miller WL. Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 2013;379:62-73.
26. Alfano J, Brownie AC, Orme-Johnson WH, Beinert H. Adrenal mitochondrial cytochrome P-450 and cholesterol side chain cleavage activity. Differences in the response of the zona glomerulosa and zona fasciculata-reticularis to adrenocorticotropic hormone and its withdrawal. J Biol Chem 1973;248:7860-7864.
27. Payne AH. Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17 alpha-hydroxylase/C17-20 lyase in Leydig cells. Biol Reprod 1990;42:399-404.
28. Schimmer BP, White PC. Minireview: steroidogenic factor 1: its roles in differentiation, development, and disease. Mol Endocrinol 2010;24:1322-1337.
29. Shih MC, Chiu YN, Hu MC, Guo IC, Chung BC. Regulation of steroid production: analysis of Cyp11a1 promoter. Mol Cell Endocrinol 2011;336:80-84.
30. Stevens VL, Tribble DL, Lambeth JD. Regulation of mitochondrial compartment volumes in rat adrenal cortex by ether stress. Arch Biochem Biophys 1985;242:324-327.
31. Privalle CT, Crivello JF, Jefcoate CR. Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P-450 in rat adrenal gland. Proc Natl Acad Sci U S A 1983;80:702-706.
32. Privalle CT, McNamara BC, Dhariwal MS, Jefcoate CR. ACTH control of cholesterol side-chain cleavage at adrenal mitochondrial cytochrome P-450scc. Regulation of intramitochondrial cholesterol transfer. Mol Cell Endocrinol 1987;53:87-101.
33. van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008;9:112-2411.
34. Ikonen E. Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 2008;9:125-138.
35. Mesmin B, Maxfield FR. Intracellular sterol dynamics. Biochim Biophys Acta 2009;1791:636-645.
36. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 2008;8:512-521.
37. Prinz WA. Lipid trafficking sans vesicles: where, why, how? Cell 2010;143:870-874.
38. Sturley SL, Hussain MM. Lipid droplet formation on opposing sides of the endoplasmic reticulum. J Lipid Res 2012;53:1800-1810.
39. Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 2009;50(Suppl):S15-S27.
40. Baumann NA, Sullivan DP, Ohvo-Rekilä H, Simonot C, Pottekat A, Klaassen Z, Beh CT, Menon AK. Transport of newly synthesized sterol to the sterol-enriched plasma membrane occurs via nonvesicular equilibration. Biochemistry 2005;44:5816-5826.
41. Zoller LC, Malamed S. Acute effects of ACTH on dissociated adrenocortical cells: quantitative changes in mitochondria and lipid droplets. Anat Rec 1975;182:473-478.
42. Nan X, Potma EO, Xie XS. Nonperturbative chemical imaging of organelle transport in living cells with coherent anti-stokes Raman scattering microscopy. Biophys J 2006;91:728-735.
43. Shen WJ, Zaidi SK, Patel S, Cortez Y, Ueno M, Azhar R, Azhar S, Kraemer FB. Ablation of vimentin results in defective steroidogenesis. Endocrinology 2012;153:3249-3257.
44. Freeman DA. Cyclic AMP mediated modification of cholesterol traffic in Leydig tumor cells. J Biol Chem 1987;262:13061-13068.
45. Freeman DA. Plasma membrane cholesterol: removal and insertion into the membrane and utilization as substrate for steroidogenesis. Endocrinology 1989;124:2527-2534.
46. Nagy L, Freeman DA. Effect of cholesterol transport inhibitors on steroidogenesis and plasma membrane cholesterol transport in cultured MA-10 Leydig tumor cells. Endocrinology 1990;126:2267-2276.
47. Lange Y, Steck TL. Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. Prog Lipid Res 2008;47:319-332.
48. Lindblom G, Orädd G. Lipid lateral diffusion and membrane heterogeneity. Biochim Biophys Acta 2009;1788:234-244.
49. Radhakrishnan A, McConnell HM. Chemical activity of cholesterol in membranes. Biochemistry 2000;39:8119-8124.
50. Lange Y, Cutler HB, Steck TL. The effect of cholesterol and other intercalated amphipaths on the contour and stability of the isolated red cell membrane. J Biol Chem 1980;255:9331-9337.
51. Steck TL, Ye J, Lange Y. Probing red cell membrane cholesterol movement with cyclodextrin. Biophys J 2002;83:2118-2125.
52. Leventis R, Silvius JR. Use of cyclodextrins to monitor transbilayer movement and differential lipid affinities of cholesterol. Biophys J 2001;81:2257-2267.
53. Radhakrishnan A, McConnell HM. Condensed complexes of cholesterol and phospholipids. Biophys J 1999;77:1507-1517.
54. Radhakrishnan A, McConnell H. Condensed complexes in vesicles containing cholesterol and phospholipids. Proc Natl Acad Sci U S A 2005;102:12662-12666.
55. McConnell HM, Radhakrishnan A. Condensed complexes of cholesterol and phospholipids. Biochim Biophys Acta 2003;1610:159-173.
56. Lange Y, Ye J, Steck TL. How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. Proc Natl Acad Sci U S A 2004;101:11664-11667.
57. Schneiter R, Brügger B, Sandhoff R, Zellnig G, Leber A, Lampl M, Athenstaedt K, Hrastnik C, Eder S, Daum G, Paltauf F, Wieland FT, Kohlwein SD. Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane. J Cell Biol 1999;146:741-754.
58. Lange Y, Ye J, Steck TL. Activation of membrane cholesterol by displacement from phospholipids. J Biol Chem 2005;280:36126-36131.
59. Ratajczak MK, Ko YT, Lange Y, Steck TL, Lee KY. Cholesterol displacement from membrane phospholipids by hexadecanol. Biophys J 2007;93:2038-2047.
60. Huang J, Feigenson GW. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys J 1999;76:2142-2157.
61. Ali MR, Cheng KH, Huang J. Assess the nature of cholesterol-lipid interactions through the chemical potential of cholesterol in phosphatidylcholine bilayers. Proc Natl Acad Sci U S A 2007;104:5372-5377.
62. Daum G, Vance JE. Import of lipids into mitochondria. Prog Lipid Res 1997;36:103-130.
63. Horvath SE, Daum G. Lipids of mitochondria. Prog Lipid Res 2013;52:590-614.
64. Wang HP, Pfeiffer DR, Kimura T, Tchen TT. Phospholipids of adrenal cortex mitochondria and the steroid hydroxylases: the lipid-environment of cytochrome P-450. Biochem Biophys Res Commun 1974;57:93-99.
65. Cheng B, Kimura T. The distribution of cholesterol and phospholipid composition in submitochondrial membranes from bovine adrenal cortex: fundamental studies of steroidogenic mitochondria. Lipids 1983;18:577-584.
66. Stevens VL, Lambeth JD, Merrill AH Jr. Use of cytochrome P-450scc to measure cholesterol-lipid interactions. Biochemistry 1986;25:4287-4292.
67. Kido T, Yamakura F, Kimura T. The transfer of cholesterol and hydroxycholesterol derivatives from liposome to soluble cytochrome P-450 scc. Biochim Biophys Acta 1981;666:370-381.
68. Kido T, Kimura T. Stimulation of cholesterol binding to steroid-free cytochrome P-450scc by poly(L-lysine). The implication in functions of labile protein factor for adrenocortical steroidogenesis. J Biol Chem 1981;256:8561-8568.
69. Igarashi Y, Kimura T. Importance of the unsaturated fatty acyl group of phospholipids in their stimulatory role on rat adrenal mitochondrial steroidogenesis. Biochemistry 1986;25:6461-6466.
70. Igarashi Y, Kimura T. Adrenic acid content in rat adrenal mitochondrial phosphatidylethanolamine and its relation to ACTH-mediated stimulation of cholesterol side chain cleavage reaction. J Biol Chem 1986;261:14118-14124.
71. Phillips MC, Johnson WJ, Rothblat GH. Mechanisms and consequences of cellular cholesterol exchange and transfer. Biochim Biophys Acta 1987;906:223-276.
72. Lev S. Non-vesicular lipid transport by lipid-transfer proteins and beyond. Nat Rev Mol Cell Biol 2010;11:739-750.
73. Clark BJ. The mammalian START domain protein family in lipid transport in health and disease. J Endocrinol 2012;212:257-275.
74. Raychaudhuri S, Prinz WA. The diverse functions of oxysterol-binding proteins. Annu Rev Cell Dev Biol 2010;26:157-177.
75. Pon LA, Orme-Johnson NR. Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. Rapid induction of a similar protein in both tissues. J Biol Chem 1986;261:6594-6599.
76. Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem 2003;278:22183-22186.
77. Iyer LM, Koonin EV, Aravind L. Adaptations of the helix-grip fold for ligand binding and catalysis in the START domain superfamily. Proteins 2001;43:134-144.
78. Pon LA, Hartigan JA, Orme-Johnson NR. Acute ACTH regulation of adrenal corticosteroid biosynthesis. Rapid accumulation of a phosphoprotein. J Biol Chem 1986;261:13309-13316.
79. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994;269:28314-28322.
80. Bose HS, Sugawara T, Strauss JF 3rd, Miller WL, International Congenital Lipoid Adrenal Hyperplasia Consortium. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N Engl J Med 1996;335:1870-1878.
81. Lin D, Sugawara T, Strauss JF 3rd, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995;267:1828-1831.
82. Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N, Miller WL. Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab 2000;85:3636-3639.
83. Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL. Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 2010;95:3352-3359.
84. Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ, Parker KL. Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. Proc Natl Acad Sci U S A 1997;94:11540-11545.
85. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996;17:221-244.
86. Arakane F, Kallen CB, Watari H, Foster JA, Sepuri NB, Pain D, Stayrook SE, Lewis M, Gerton GL, Strauss JF 3rd. The mechanism of action of steroidogenic acute regulatory protein (StAR). StAR acts on the outside of mitochondria to stimulate steroidogenesis. J Biol Chem 1998;273:16339-16345.
87. Bose HS, Lingappa VR, Miller WL. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 2002;417:87-91.
88. Sasaki G, Ishii T, Jeyasuria P, Jo Y, Bahat A, Orly J, Hasegawa T, Parker KL. Complex role of the mitochondrial targeting signal in the function of steroidogenic acute regulatory protein revealed by bacterial artificial chromosome transgenesis in vivo. Mol Endocrinol 2008;22:951-964.
89. Tsujishita Y, Hurley JH. Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol 2000;7:408-414.
90. Romanowski MJ, Soccio RE, Breslow JL, Burley SK. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc Natl Acad Sci U S A 2002;99:6949-6954.
91. Thorsell AG, Lee WH, Persson C, Siponen MI, Nilsson M, Busam RD, Kotenyova T, Schüler H, Lehtiö L. Comparative structural analysis of lipid binding START domains. PLoS One 2011;6:e19521.
92. Murcia M, Faráldo-Gómez JD, Maxfield FR, Roux B. Modeling the structure of the StART domains of MLN64 and StAR proteins in complex with cholesterol. J Lipid Res 2006;47:2614-2630.
93. Barbar E, Lavigne P, Lehoux JG. Validation of the mechanism of cholesterol binding by StAR using short molecular dynamics simulations. J Steroid Biochem Mol Biol 2009;113:92-97.
94. Kallen CB, Billheimer JT, Summers SA, Stayrook SE, Lewis M, Strauss JF 3rd. Steroidogenic acute regulatory protein (StAR) is a sterol transfer protein. J Biol Chem 1998;273:26285-26288.
95. Petrescu AD, Gallegos AM, Okamura Y, Strauss JF 3rd, Schroeder F. Steroidogenic acute regulatory protein binds cholesterol and modulates mitochondrial membrane sterol domain dynamics. J Biol Chem 2001;276:36970-36982.
96. Tuckey RC, Headlam MJ, Bose HS, Miller WL. Transfer of cholesterol between phospholipid vesicles mediated by the steroidogenic acute regulatory protein (StAR). J Biol Chem 2002;277:47123-47128.
97. Artemenko IP, Zhao D, Hales DB, Hales KH, Jefcoate CR. Mitochondrial processing of newly synthesized steroidogenic acute regulatory protein (StAR), but not total StAR, mediates cholesterol transfer to cytochrome P450 side chain cleavage enzyme in adrenal cells. J Biol Chem 2001;276:46583-46596.
98. Baker BY, Epand RF, Epand RM, Miller WL. Cholesterol binding does not predict activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem 2007;282:10223-10232.
99. Bose M, Whittal RM, Miller WL, Bose HS. Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. J Biol Chem 2008;283:8837-8845.
100. Bose HS, Whittal RM, Baldwin MA, Miller WL. The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc Natl Acad Sci U S A 1999;96:7250-7255.
101. Baker BY, Yaworsky DC, Miller WL. A pH-dependent molten globule transition is required for activity of the steroidogenic acute regulatory protein, StAR. J Biol Chem 2005;280:41753-41760.
102. Yaworsky DC, Baker BY, Bose HS, Best KB, Jensen LB, Bell JD, Baldwin MA, Miller WL. pH-dependent Interactions of the carboxyl-terminal helix of steroidogenic acute regulatory protein with synthetic membranes. J Biol Chem 2005;280:2045-2054.
103. Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269-281.
104. Park WD, O'Brien JF, Lundquist PA, Kraft DL, Vockley CW, Karnes PS, Patterson MC, Snow K. Identification of 58 novel mutations in Niemann-Pick disease type C: correlation with biochemical phenotype and importance of PTC1-like domains in NPC1. Hum Mutat 2003;22:313-325.
105. Naureckiene S, Sleat DE, Lackland H, Fensom A, Vanier MT, Wattiaux R, Jadot M, Lobel P. Identification of HE1 as the second gene of Niemann-Pick C disease. Science 2000;290:2298-2301.
106. Kwon HJ, Abi-Mosleh L, Wang ML, Deisenhofer J, Goldstein JL, Brown MS, Infante RE. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 2009 Jun 26;137:1213-1224.
107. Xu S, Benoff B, Liou HL, Lobel P, Stock AM. Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease. J Biol Chem 2007;282:23525-23531.
108. Wang ML, Motamed M, Infante RE, Abi-Mosleh L, Kwon HJ, Brown MS, Goldstein JL. Identification of surface residues on Niemann-Pick C2 essential for hydrophobic handoff of cholesterol to NPC1 in lysosomes. Cell Metab 2010;12:166-173.
109. Infante RE, Wang ML, Radhakrishnan A, Kwon HJ, Brown MS, Goldstein JL. NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc Natl Acad Sci U S A 2008;105:15287-15292.
110. Pentchev PG, Comly ME, Kruth HS, Patel S, Proestel M, Weintroub H. The cholesterol storage disorder of the mutant BALB/c mouse. A primary genetic lesion closely linked to defective esterification of exogenously derived cholesterol and its relationship to human type C Niemann-Pick disease. J Biol Chem 1986;261:2772-2777.
111. Roff CF, Strauss JF 3rd, Goldin E, Jaffe H, Patterson MC, Agritellis GC, Hibbs AM, Garfield M, Brady RO, Pentchev PG. The murine Niemann-Pick type C lesion affects testosterone production. Endocrinology 1993;133:2913-2923.
112. Tomasetto C, Régnier C, Moog-Lutz C, Mattei MG, Chenard MP, Lidereau R, Basset P, Rio MC. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 1995;28:367-376.
113. Jacot W, Fiche M, Zaman K, Wolfer A, Lamy PJ. The HER2 amplicon in breast cancer: topoisomerase IIA and beyond. Biochim Biophys Acta 2013;1836:146-157.
114. Sahlberg KK, Hongisto V, Edgren H, Mäkelä R, Hellström K, Due EU, Moen Vollan HK, Sahlberg N, Wolf M, Børresen-Dale AL, Perälä M, Kallioniemi O. The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells. Mol Oncol 2013;7:392-401.
115. Akula N, Midzak A, Lecanu L, Papadopoulos V. Identification of small-molecule inhibitors of the steroidogenic acute regulatory protein (STARD1) by structure-based design. Bioorg Med Chem Lett 2012;22:4139-4143.
116. Chitrala KN, Yeguvapalli S. Ligand-based virtual screening to predict inhibitors against metastatic lymph node 64. J Recept Signal Transduct Res 2014;34:92-96.
117. Alpy F, Wendling C, Rio MC, Tomasetto C. MENTHO, a MLN64 homologue devoid of the START domain. J Biol Chem 2002;277:50780-50787.
118. Bose HS, Whittal RM, Huang MC, Baldwin MA, Miller WL. N-218 MLN64, a protein with StAR-like steroidogenic activity, is folded and cleaved similarly to StAR. Biochemistry 2000;39:11722-11731.
119. Watari H, Arakane F, Moog-Lutz C, Kallen CB, Tomasetto C, Gerton GL, Rio MC, Baker ME, Strauss JF 3rd. MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A 1997;94:8462-8467.
120. Liapis A, Chen FW, Davies JP, Wang R, Ioannou YA. MLN64 transport to the late endosome is regulated by binding to 14-3-3 via a non-canonical binding site. PLoS One 2012;7:e34424.
121. Alpy F, Latchumanan VK, Kedinger V, Janoshazi A, Thiele C, Wendling C, Rio MC, Tomasetto C. Functional characterization of the MENTAL domain. J Biol Chem 2005;280:17945-17952.
122. Zhang M, Liu P, Dwyer NK, Christenson LK, Fujimoto T, Martinez F, Comly M, Hanover JA, Blanchette-Mackie EJ, Strauss JF 3rd. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J Biol Chem 2002;277:33300-33310.
123. Charman M, Kennedy BE, Osborne N, Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J Lipid Res 2010;51:1023-1034.
124. Olvera-Sanchez S, Espinosa-Garcia MT, Monreal J, Flores-Herrera O, Martinez F. Mitochondrial heat shock protein participates in placental steroidogenesis. Placenta 2011;32:222-229.
125. Bose HS, Whittal RM, Ran Y, Bose M, Baker BY, Miller WL. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry 2008;47:2277-2288.
126. Ren S, Hylemon P, Marques D, Hall E, Redford K, Gil G, Pandak WM. Effect of increasing the expression of cholesterol transporters (StAR, MLN64, and SCP-2) on bile acid synthesis. J Lipid Res 2004;45:2123-2131.
127. Kishida T, Kostetskii I, Zhang Z, Martinez F, Liu P, Walkley SU, Dwyer NK, Blanchette-Mackie EJ, Radice GL, Strauss JF 3rd. Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J Biol Chem 2004;279:19276-19285.
128. Hölttä-Vuori M, Alpy F, Tanhuanpää K, Jokitalo E, Mutka AL, Ikonen E. MLN64 is involved in actin-mediated dynamics of late endocytic organelles. Mol Biol Cell 2005;16:3873-3886.
129. van der Kant R, Zondervan I, Janssen L, Neefjes J. Cholesterol-binding molecules MLN64 and ORP1L mark distinct late endosomes with transporters ABCA3 and NPC1. J Lipid Res 2013;54:2153-2165.
130. Alpy F, Rousseau A, Schwab Y, Legueux F, Stoll I, Wendling C, Spiegelhalter C, Kessler P, Mathelin C, Rio MC, Levine TP, Tomasetto C. STARD3 or STARD3NL and VAP form a novel molecular tether between late endosomes and the ER. J Cell Sci 2013;126:5500-5512.
131. Li B, Vachali P, Frederick JM, Bernstein PS. Identification of StARD3 as a lutein-binding protein in the macula of the primate retina. Biochemistry 2011;50:2541-2549.
132. Vachali P, Li B, Nelson K, Bernstein PS. Surface plasmon resonance (SPR) studies on the interactions of carotenoids and their binding proteins. Arch Biochem Biophys 2012;519:32-37.
133. Tabunoki H, Sugiyama H, Tanaka Y, Fujii H, Banno Y, Jouni ZE, Kobayashi M, Sato R, Maekawa H, Tsuchida K. Isolation, characterization, and cDNA sequence of a carotenoid binding protein from the silk gland of Bombyx mori larvae. J Biol Chem 2002;277:32133-32140.
134. Soccio RE, Adams RM, Romanowski MJ, Sehayek E, Burley SK, Breslow JL. The cholesterol-regulated StarD4 gene encodes a StAR-related lipid transfer protein with two closely related homologues, StarD5 and StarD6. Proc Natl Acad Sci U S A 2002;99:6943-6948.
135. Alpy F, Tomasetto C. Give lipids a START: the StAR-related lipid transfer (START) domain in mammals. J Cell Sci 2005;118:2791-2801.
136. Rodriguez-Agudo D, Calderon-Dominguez M, Ren S, Marques D, Redford K, Medina-Torres MA, Hylemon P, Gil G, Pandak WM. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim Biophys Acta 2011;1811:597-606.
137. Chen YC, Meier RK, Zheng S, Khundmiri SJ, Tseng MT, Lederer ED, Epstein PN, Clark BJ. Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules. Am J Physiol Renal Physiol 2009;297:F380-F388.
138. Soccio RE, Adams RM, Maxwell KN, Breslow JL. Differential gene regulation of StarD4 and StarD5 cholesterol transfer proteins. Activation of StarD4 by sterol regulatory element-binding protein-2 and StarD5 by endoplasmic reticulum stress. J Biol Chem 2005;280:19410-19418.
139. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 2003;100:12027-12032.
140. Rodriguez-Agudo D, Ren S, Wong E, Marques D, Redford K, Gil G, Hylemon P, Pandak WM. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J Lipid Res 2008;49:1409-1419.
141. Mesmin B, Pipalia NH, Lund FW, Ramlall TF, Sokolov A, Eliezer D, Maxfield FR. STARD4 abundance regulates sterol transport and sensing. Mol Biol Cell 2011;22:4004-4015.
142. Riegelhaupt JJ, Waase MP, Garbarino J, Cruz DE, Breslow JL. Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. J Lipid Res 2010;51:1134-1143.
143. Ishikawa T, Morris PL. Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells. Endocrinology 2006;147:5424-5430.
144. Rodriguez-Agudo D, Ren S, Hylemon PB, Montañez R, Redford K, Natarajan R, Medina MA, Gil G, Pandak WM. Localization of StarD5 cholesterol binding protein. J Lipid Res 2006;47:1168-1175.
145. Rodriguez-Agudo D, Ren S, Hylemon PB, Redford K, Natarajan R, Del Castillo A, Gil G, Pandak WM. Human StarD5, a cytosolic StAR-related lipid binding protein. J Lipid Res 2005;46:1615-1623.
146. Rodriguez-Agudo D, Calderon-Dominguez M, Medina MA, Ren S, Gil G, Pandak WM. ER stress increases StarD5 expression by stabilizing its mRNA and leads to relocalization of its protein from the nucleus to the membranes. J Lipid Res 2012;53:2708-2715.
147. Létourneau D, Lorin A, Lefebvre A, Frappier V, Gaudreault F, Najmanovich R, Lavigne P, LeHoux JG. StAR-related lipid transfer domain protein 5 binds primary bile acids. J Lipid Res 2012;53:2677-2689.
148. Létourneau D, Lorin A, Lefebvre A, Cabana J, Lavigne P, LeHoux JG. Thermodynamic and solution state NMR characterization of the binding of secondary and conjugated bile acids to STARD5. Biochim Biophys Acta 2013;1831:1589-1599.
149. Gomes C, Oh SD, Kim JW, Chun SY, Lee K, Kwon HB, Soh J. Expression of the putative sterol binding protein Stard6 gene is male germ cell specific. Biol Reprod 2005;72:651-658.
150. Chang IY, Kim JH, Cho KW, Yoon SP. Acute responses of DNA repair proteins and StarD6 in rat hippocampus after domoic acid-induced excitotoxicity. Acta Histochem 2013;115:234-239.
151. Lavoie HA, Whitfield NE, Shi B, King SR, Bose HS, Hui YY. STARD6 is expressed in steroidogenic cells of the ovary and can enhance de novo steroidogenesis. Exp Biol Med (Maywood) 2014;239:430-435.
152. Taylor FR, Saucier SE, Shown EP, Parish EJ, Kandutsch AA. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J Biol Chem 1984;259:12382-12387.
153. Nishimura T, Inoue T, Shibata N, Sekine A, Takabe W, Noguchi N, Arai H. Inhibition of cholesterol biosynthesis by 25-hydroxycholesterol is independent of OSBP. Genes Cells 2005;10:793-801.
154. Jaworski CJ, Moreira E, Li A, Lee R, Rodriguez IR. A family of 12 human genes containing oxysterol-binding domains. Genomics 2001;78:185-196.
155. Lehto M, Laitinen S, Chinetti G, Johansson M, Ehnholm C, Staels B, Ikonen E, Olkkonen VM. The OSBP-related protein family in humans. J Lipid Res 2001;42:1203-1213.
156. Mesmin B, Antonny B, Drin G. Insights into the mechanisms of sterol transport between organelles. Cell Mol Life Sci 2013;70:3405-3421.
157. Ngo MH, Colbourne TR, Ridgway ND. Functional implications of sterol transport by the oxysterol-binding protein gene family. Biochem J 2010;429:13-24.
158. Olkkonen VM, Li S. Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog Lipid Res 2013;52:529-538.
159. de Saint-Jean M, Delfosse V, Douguet D, Chicanne G, Payrastre B, Bourguet W, Antonny B, Drin G. Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers. J Cell Biol 2011;195:965-978.
160. Mesmin B, Bigay J, Moser von Filseck J, Lacas-Gervais S, Drin G, Antonny B. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 2013;155:830-843.
161. Krueger KE, Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J Biol Chem 1990;265:15015-15022.
162. Papadopoulos V, Mukhin AG, Costa E, Krueger KE. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J Biol Chem 1990;265:3772-3779.
163. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 2006;27:402-409.
164. Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 1991;129:1481-1488.
165. Papadopoulos V, Nowzari FB, Krueger KE. Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. Tropic hormone action on steroid biosynthesis is inhibited by flunitrazepam. J Biol Chem 1991;266:3682-3687.
166. Papadopoulos V, Amri H, Li H, Boujrad N, Vidic B, Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J Biol Chem 1997;272:32129-32135.
167. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 2014;155:89-97.
168. Papadopoulos V. On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology 2014;155:15-20.
169. Austin CJ, Kahlert J, Kassiou M, Rendina LM. The translocator protein (TSPO): a novel target for cancer chemotherapy. Int J Biochem Cell Biol 2013;45:1212-1216.
170. Qi X, Xu J, Wang F, Xiao J. Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases. Oxid Med Cell Longev 2012;2012:162934.
171. Gatliff J, Campanella M. The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med 2012;12:356-368.
172. Scarf AM, Kassiou M. The translocator protein. J Nucl Med 2011;52:677-680.
173. Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 2010;9:971-988.
174. Papadopoulos V, Lecanu L. Translocator protein (18 kDa) TSPO: an emerging therapeutic target in neurotrauma. Exp Neurol 2009;219:53-57.
175. Li H, Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 1998;139:4991-4997.
176. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci U S A 2001;98:1267-1272.
177. Lacapère JJ, Delavoie F, Li H, Péranzi G, Maccario J, Papadopoulos V, Vidic B. Structural and functional study of reconstituted peripheral benzodiazepine receptor. Biochem Biophys Res Commun 2001;284:536-541.
178. Jamin N, Neumann JM, Ostuni MA, Vu TK, Yao ZX, Murail S, Robert JC, Giatzakis C, Papadopoulos V, Lacapère JJ. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 2005;19:588-594.
179. Midzak A, Akula N, Lecanu L, Papadopoulos V. Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J Biol Chem 2011;286:9875-9887.
180. Jaremko L, Jaremko M, Giller K, Becker S, Zweckstetter M. Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 2014;343:1363-1366.
181. Baier CJ, Fantini J, Barrantes FJ. Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci Rep 2011;1:69.
182. Fantini J, Barrantes FJ. How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol 2013;4:31.
183. Midzak A, Rammouz G, Papadopoulos V. Structure-activity relationship (SAR) analysis of a family of steroids acutely controlling steroidogenesis. Steroids 2012;77:1327-1334.
184. Delavoie F, Li H, Hardwick M, Robert JC, Giatzakis C, Péranzi G, Yao ZX, Maccario J, Lacapère JJ, Papadopoulos V. In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding. Biochemistry 2003;42:4506-4519.
185. Culty M, Li H, Boujrad N, Amri H, Vidic B, Bernassau JM, Reversat JL, Papadopoulos V. J Steroid Biochem Mol Biol 1999;69:123-130.
186. Garnier M, Dimchev AB, Boujrad N, Price JM, Musto NA, Papadopoulos V. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol Pharmacol 1994;45:201-211.
187. Campbell AM, Chan SH. The voltage dependent anion channel affects mitochondrial cholesterol distribution and function. Arch Biochem Biophys 2007;466:203-210.
188. Hauet T, Yao ZX, Bose HS, Wall CT, Han Z, Li W, Hales DB, Miller WL, Culty M, Papadopoulos V. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Mol Endocrinol 2005;19:540-554.
189. West LA, Horvat RD, Roess DA, Barisas BG, Juengel JL, Niswender GD. Steroidogenic acute regulatory protein and peripheral-type benzodiazepine receptor associate at the mitochondrial membrane. Endocrinology 2001;142:502-505.
190. Liu J, Rone MB, Papadopoulos V. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J Biol Chem 2006;281:38879-38893.
191. Bogan RL, Davis TL, Niswender GD. Peripheral-type benzodiazepine receptor (PBR) aggregation and absence of steroidogenic acute regulatory protein (StAR)/PBR association in the mitochondrial membrane as determined by bioluminescence resonance energy transfer (BRET). J Steroid Biochem Mol Biol 2007;104:61-67.
192. Li H, Degenhardt B, Tobin D, Yao ZX, Tasken K, Papadopoulos V. Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIalpha)-associated protein. Mol Endocrinol 2001;15:2211-2228.
193. Rone MB, Midzak AS, Issop L, Rammouz G, Jagannathan S, Fan J, Ye X, Blonder J, Veenstra T, Papadopoulos V. Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol Endocrinol 2012;26:1868-1882.